Loading...

CymaBay Therapeutics, Inc.

CBAY•NASDAQ
Healthcare
Biotechnology
$32.48
$0.010(0.03%)

CymaBay Therapeutics, Inc. (CBAY) Stock Chart & Performance Analysis

Explore CymaBay Therapeutics, Inc.’s stock chart, historical data, and performance trends for a deeper market understanding.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
0.03%
3-Month Change
32.57%
6-Month Change
138.65%
Year-to-Date (YTD) Change
36.99%
1-Year Change
215.95%
3-Year Change
678.90%
5-Year Change
169.54%
All-Time (Max) Change
260.89%

Analyzing CymaBay Therapeutics, Inc. (CBAY) Trends Across Multiple Time Frames

CymaBay Therapeutics, Inc. Charts reveal critical insights by breaking down performance into different periods from short-term swings to long-term trends. CymaBay Therapeutics, Inc. stock shows N/A 1-day change, indicating low volatility, while its 5-day change of N/A suggests a broader trend. Over a 1-month period, a 0.03% rise could signal a pushback, whereas a 3-month rise of 32.57% may reflect broader market sentiment. Longer timeframes help assess sustained performance. A 6-month change of 138.65% and a YTD rise of 36.99% might concern investors, but a 1-year gain of 215.95% and a 3-year increase of 678.90% could indicate resilience. The 5-year surge of 169.54% highlights strong historical growth, while the all-time return of 260.89% underscores long-term potential. Whether tracking intraday moves or multi-year trends, analyzing these metrics helps traders and investors make data-driven decisions.

Frequently Asked Questions

;